Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
Loreta A. Kondili(Istituto Superiore di Sanità), Ivan Gentile(University of Naples Federico II), Giovanni Battista Gaeta, Luisa Cavalletto(University of Padua), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Anna Licata(University of Palermo), Mauro Viganò(Ospedale San Giuseppe), Guglielmo Marco Migliorino(Azienda Ospedaliera San Gerardo), Vincenza Calvaruso(University of Palermo), Luigina Ferrigno(Departamento de Epidemiología), Luchino Chessa(University of Cagliari), Mario Masarone(University of Salerno), Francesco Paolo Russo(University of Padua), Pierluigi Blanc, Anna Linda Zignego(University of Florence), Monica Monti(University of Florence), Valentina Panetta, Salvatore Madonia(Ospedale Vincenzo Cervello), Andrea Iannone(University of Bari Aldo Moro), Marcello Persico(University of Salerno), Gabriella Verucchi(University of Bologna), Lorenzo Badia(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Martina De Siena, Roberto Filomia(University of Messina), Ilaria Simonelli(Data Management (Italy)), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Gloria Taliani(Sapienza University of Rome), Liliana Chemello(University of Padua), Erica Villa(University of Modena and Reggio Emilia), Giovanni Raimondo(University of Messina), Alessia Giorgini(Università Cattolica del Sacro Cuore), Carlo Ferrari(University of Parma), Maurizio Pompili, B. Coco(Azienda Ospedaliera Universitaria Pisana), Maurizia Rossana Brunetto(University of Pisa), Xhimi Tata, Teresa Santantonio(Ospedali Riuniti di Foggia), Valentina Cossiga(University of Naples Federico II), Elisa Biliotti(Sapienza University of Rome), Donatella Ieluzzi(University of Verona), Maria Grazia Rumi(University of Milan), Antonio Craxı̀(University of Palermo), Francesco Barbaro(University of Padua), Giuseppina Brancaccio, Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Carmine Coppola, Maria Giovanna Quaranta(Istituto Superiore di Sanità), Daniela Caterina Amoruso, Filomena Morisco
Cited by 15
Related Papers
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661